Cat allergy vaccine update: Circassia Achieves Successful Phase II Clinical Results With ToleroMune® Anti-Allergy Technology

According to Circassia, Ltd., which is in the process of human clinical trials of their upcoming cat allergy vaccine, ToleroMune®, they have achieved promising results from their phase II clinical study. As their recent media release states: Circassia Ltd, a specialty biopharmaceutical company focused on controlling immune system responses, today announced positive results from a phase…

Article in Allergic Living: Surveys Show Low Level of Allergy Awareness

In this recent article in Allergic Living Magazine, we read about two surveys that reveal just how unprepared members of the general public are to respond to allergic reactions. Given the increasing prevalence of allergies in the population, with up to 15 million Americans and between 2 and 3 million Canadians suffering from food allergies…

Exciting news! Cat allergy vaccine trials now recruiting!

I’ve been following the development of the cat allergy vaccine since it was first announced a few years ago. The clinical trials are now in the home stretch, and if approved, the vaccine may be available as early as 2015. This is wonderful news for cat lovers with allergies. Whether the cat allergy vaccine will…

The Economist on allergy desensitization

Desensitization to peanuts has been in the news recently. Here is a brief summary by The Economist. Sensationalism-free for your reading pleasure. This is exciting research, and I hope it helps many. An important reminder from the article, however: This is not, the researchers emphasise, an experiment that anyone should attempt at home. Even under…